Daniel Gröner

14PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markersSpeech recognitionCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 03, 2025
Somatostatin Receptor-Directed Theranostics in Esthesioneuroblastoma.

Yingjun Zhi, Sebastian E Serfling, Daniel Groener

|Dec 06, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.

Mike Wenzel, Florestan Koll, Benedikt Hoeh

|Nov 21, 2024
Norepinephrine Transporter-Targeted Cancer Theranostics-New Horizons.

Takahiro Higuchi, Konrad Klimek, Daniel Groener

|Oct 16, 2024
Interobserver Agreement in Ultrasound Risk Stratification Systems for Thyroid Nodules on Static Images Versus Cine-Loop Video Sequences.

Simone Agnes Schenke, Manuela Petersen, Rainer Görges

|Sep 28, 2023
Intermittent Radioligand Therapy with <sup>177</sup>Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.

Nicolai Mader, Christina Schoeler, Niloufar Pezeshkpour

|Aug 12, 2023
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT.

Daniel Groener, Jennifer Wichert, Magdalena Adams

Pageof 3

Frequent Collaborators

8 joint publications

Amir Sabet

6 joint publications

Nicolai Mader

3 joint publications

Michael Christoph Kreissl

2 joint publications

Michael Grunert